The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Gene-Expression Profiling for Rejection Surveillance after Cardiac Transplantation
Open accessAbstract
BACKGROUND: Endomyocardial biopsy is the standard method of monitoring for rejection in recipients of a cardiac transplant. However, this procedure is uncomfortable, and there are risks associated with it. Gene-expression profiling of peripheral-blood specimens has been shown to correlate with the results of an endomyocardial biopsy. METHODS: We randomly assigned 602 patients who had undergone cardiac transplantation 6 months to 5 years previously to be monitored for rejection with the use of gene-expression profiling or with the use of routine endomyocardial biopsies, in addition to clinical and echocardiographic assessment of graft function. We performed a noninferiority comparison of the two approaches with respect to the composite primary outcome of rejection with hemodynamic compromise, graft dysfunction due to other causes, death, or retransplantation. RESULTS: During a median follow-up period of 19 months, patients who were monitored with gene-expression profiling and those who underwent routine biopsies had similar 2-year cumulative rates of the composite primary outcome (14.5% and 15.3%, respectively; hazard ratio with gene-expression profiling, 1.04; 95% confidence interval, 0.67 to 1.68). The 2-year rates of death from any cause were also similar in the two groups (6.3% and 5.5%, respectively; P=0.82). Patients who were monitored with the use of gene-expression profiling underwent fewer biopsies per person-year of follow-up than did patients who were monitored with the use of endomyocardial biopsies (0.5 vs. 3.0, P<0.001). CONCLUSIONS: Among selected patients who had received a cardiac transplant more than 6 months previously and who were at a low risk for rejection, a strategy of monitoring for rejection that involved gene-expression profiling, as compared with routine biopsies, was not associated with an increased risk of serious adverse outcomes and resulted in the performance of significantly fewer biopsies. (ClinicalTrials.gov number, NCT00351559.)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
J Heart Lung Transplant 2021;40(4).
(2021) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2021.04.002 · Cited by 6,665
Deng, M. C., Eisen, H. J., Mehra, M. R., Billingham, M., Marboe, C. C., Berry, G., Kobashigawa, J., Johnson, F. L., Starling, R. C., Murali, S., et al. (2006) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2005.01175.x · Cited by 524
Self-citationTaylor, D. O., Stehlik, J., Edwards, L. B., Aurora, P., Christie, J. D., Dobbels, F., Kirk, R., Kucheryavaya, A. Y., Rahmel, A. O., & Hertz, M. I. (2009) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2009.08.014 · Cited by 421
Taylor, D. O., Edwards, L. B., Boucek, M. M., Trulock, E. P., Deng, M. C., Keck, B. M., & Hertz, M. I. (2005) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2005.05.018 · Cited by 409
Self-citationDaclizumab to Prevent Rejection after Cardiac Transplantation
Hershberger, R. E., Starling, R. C., Eisen, H. J., Bergh, C.-H., Kormos, R. L., Love, R. B., Van Bakel, A., Gordon, R. D., Popat, R., Cockey, L., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa032953 · Cited by 205
Self-citationComplications of endomyocardial biopsy in heart transplant patients.
Baraldi-Junkins, C., Levin, H. R., Kasper, E. K., Rayburn, B. K., Herskowitz, A., & Baughman, K. L. (1993) · PubMed · Cited by 178
Horwitz, P. A., Tsai, E. J., Putt, M., Gilmore, J. M., Lepore, J. J., Parmacek, M. S., Kao, A. C., Desai, S., Goldberg, L. R., Brozena, S. C., et al. (2004) · Circulation · doi:10.1161/01.cir.0000150539.72783.bf · Cited by 159
Self-citationRaichlin, E., Edwards, B. S., Kremers, W. K., Clavell, A. L., Rodeheffer, R. J., Frantz, R. P., Pereira, N. L., Daly, R. C., McGregor, C. G., Lerman, A., et al. (2009) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2009.01.006 · Cited by 158
Marboe, C. C., Billingham, M. E., Eisen, H. J., Deng, M. C.-H. K., Baron, H. M., Mehra, M. R., Hunt, S. A., Wohlgemuth, J. G., Mahmood, I., Prentice, J., et al. (2005) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2005.04.001 · Cited by 155
Self-citationMills, R. M., Naftel, D. C., Kirklin, J. K., Bakel, A. B. V., Jaski, B. E., Massin, E. K., Eisen, H. J., Lee, F. A., Fishbein, D. P., & Bourge, R. C. (1997) · PubMed · Cited by 143
Molecular Testing in the Management of Cardiac Transplant Recipients: Initial Clinical Experience
Starling, R. C., Pham, M., Valantine, H. A., et al. (2006) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2006.10.002 · Cited by 106
Self-citationUtility of Long-term Surveillance Endomyocardial Biopsy: A Multi-institutional Analysis
Stehlik, J., Starling, R. C., Movsesian, M. A., Fang, J. C., Brown, R. N., Hess, M. L., Lewis, N. P., & Kirklin, J. K. (2006) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2006.10.003 · Cited by 95
Self-citationWilliams, M. J. A., Lee, M., DiSalvo, T. G., Dec, G. W., Picard, M. H., Palacios, I. F., & Semigran, M. J. (1996) · The American Journal of Cardiology · doi:10.1016/s0002-9149(96)00202-0 · Cited by 88
Limited Utility of Endomyocardial Biopsy in the First Year after Heart Transplantation
Hamour, I. M., Burke, M., Bell, A. D., Panicker, M. G., Banerjee, R., & Banner, N. R. (2008) · Transplantation · doi:10.1097/tp.0b013e318168d571 · Cited by 65
Factors predicting 10-year survival after heart transplantation
Radovančević, B., Konuralp, C., Vrtovec, B., Radovancevic, R., Thomas, C. D., Zaqqa, M., Vaughn, W. K., & Frazier, O. H. (2005) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2003.11.399 · Cited by 65
Rocca, H. B., Schneider, J., nzli, A. K., Turina, M., & Kiowski, W. (1998) · Transplantation · doi:10.1097/00007890-199802270-00015 · Cited by 65
Data and Safety Monitoring Boards
Friedman, L. M. (2002) · Elsevier eBooks · doi:10.1016/b978-012274065-7/50008-3 · Cited by 48
Pham, M., Deng, M. C.-H. K., Kfoury, A. G., Teuteberg, J. J., Starling, R. C., & Valantine, H. A. (2007) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2007.05.017 · Cited by 43
Self-citation
Cited by
Costanzo, M. R., Costanzo, M. R., Dipchand, A., Starling, R., Anderson, A., Chan, M., Desai, S., Fedson, S., Fisher, P., Gonzales-Stawinski, G., et al. (2010) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2010.05.034 · Cited by 1,653
Self-citationCirculating Cell-Free DNA Enables Noninvasive Diagnosis of Heart Transplant Rejection
De Vlaminck, I., Valantine, H. A., Snyder, T. M., Strehl, C., Cohen, G., Luikart, H., Neff, N. F., Okamoto, J., Bernstein, D., Weisshaar, D., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3007803 · Cited by 549
Self-citationLeone, O., Veinot, J. P., Angelini, A., Baandrup, U. T., Basso, C., Berry, G., Bruneval, P., Burke, M., Butany, J., Calabrese, F., et al. (2012) · Cardiovascular Pathology · doi:10.1016/j.carpath.2011.10.001 · Cited by 535
Personalized Medicine: Progress and Promise
Chan, I. S., & Ginsburg, G. S. (2011) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-082410-101446 · Cited by 399
Universal noninvasive detection of solid organ transplant rejection
Snyder, T. M., Khush, K. K., Valantine, H. A., & Quake, S. R. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1013924108 · Cited by 385
Self-citation
Metadata
- Authors
- Pham, M. X., Teuteberg, J. J., Kfoury, A. G., Starling, R. C., Deng, M. C., Cappola, T. P., Kao, A., Anderson, A. S., Cotts, W. G., Ewald, G. A., Baran, D. A., Bogaev, R. C., Elashoff, B., Baron, H., Yee, J., & Valantine, H. A.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2010-05-20
- Volume
- 362
- Issue
- 20
- Pages
- 1890-1900
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2138450760
- Cited by
- 520
- References
- 18
- FWCI
- 43.47
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.